Pharmacology and clinical assessment of cariporide for the treatment coronary artery diseases

Bibliography

• ORLOWSKI J, GRINSTEIN S: Neal+ exchangers of mammalian cells. J. Biol. Chem. (1997) 272:22373–22376.
   PubMed Web of Science ®Google Scholar
• NUMATA M, PETRECCA K, LAKE N, ORLOWSKI J: Identifi-cation of a mitochondrial Neill+ exchanger. J. Biol. Chem. (1998) 273:6951–6959.
   PubMed Web of Science ®Google Scholar
• KARMAZYN M, FROHLICH O: The Na-H exchanger revisited: an update on Na-H exchange regulation and the role of the exchanger in cardiac function in hypertension and cardiac function in health and disease. Cardiovasc. Res. (1997) 36:138–148.
   PubMed Web of Science ®Google Scholar
• KARMAZYN M, GAN XT, HUMPHREYS RA, YOSHIDA H, KUSUMOTO K: The myocardial Na+-11+ exchange: structure, regulation and its role in heart disease. Circ. Res. (1999) 85:777–786.
   PubMed Web of Science ®Google Scholar
• WAKABAYASHI S, SHIGEKAWA M, POUYSSEGUR J: Molecular physiology of vertebrate Na+/H+ exchangers. Physiol. Rev. (1997) 77:51–74.
   PubMed Web of Science ®Google Scholar
• KLEYMAN TR, CRAGOE EJ: Amiloride and its analogs as tools in the study of ion transport. J. Membr. Biol. (1988) 105:1–21.
   PubMed Web of Science ®Google Scholar
• KARMAZYN M: The sodium-hydrogen exchange systemin the heart: its role in ischemic and reperfusion injury and thereapeutic implications. Can. J. Cardiol (1996) 12:1074–1082.
   PubMed Web of Science ®Google Scholar
• SCHOLZ W, ALBUS U, COUNILLON L et al.: Protectiveeffects of HOE 642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc. Res. (1995) 29:260–268.
   PubMed Web of Science ®Google Scholar
• KLEEMANN HW, WEICHERT AG: Recent developmentsin the field of inhibitors of the Neill+ exchanger. IDrugs (1999) 2:1009–1025.
   PubMedGoogle Scholar
• ORLOWSKI J, KANDASAMY RA: Delineation of transmembrane domains of the Neal+ exchanger that confer sensitivity to pharmacological antagonists. J. Biol. Chem. (1996) 271:19922–19927.
   PubMed Web of Science ®Google Scholar
• LAZDUNSKI M, FRELIN C, VIGNE P: The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J. Mol Cell. Cardiol (1985) 17:1029–1042.
   PubMed Web of Science ®Google Scholar
• HOQUE ANE, HAIST JV, KARMAZYN M: Na+-11+ exchangeinhibition protects against mechanical, ultrastruc-tural and biochemical impairment induced by low concentrations of lysophosphatidylcholine in isolated rat hearts. Circ. Res. (1997) 80:95–102.
   PubMed Web of Science ®Google Scholar
• SABRI A, BYRON KL, SAMAREL AM, BELL J, LUCCHESI PA:Hydrogen peroxide activates mitogen-activated protein kinases and Nat'l+ exchange in neonatal rat cardiac myocytes. Circ. Res. (1998) 82:1053–1062.
   PubMed Web of Science ®Google Scholar
• MURRY CE, RICHARD VJ, REIMER KA, JENNINGS RB: Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ. Res. (1990) 66:913–931.
   PubMed Web of Science ®Google Scholar
• GUMINA RJ, BUERGER E, EICKMEIER C, MOORE J,DAEMMGEN J, GROSS GJ: Inhibition of Neill+ exchanger confers greater cardioprotection against 90 min of myocardial ischaemia than ischemic precondi-tioning in dogs. Circulation (1999) 100:2519–2526.
   PubMed Web of Science ®Google Scholar
• INSERTE J, GARCIA-DORADO D, RUIZ-MEANA M, SOLARES J, SOLER J: The role of Neill+ exchange occurring during hypoxia in the genesis of reoxygenation-induced myocardial oedema. J. Mol. Cardiol (1997) 29:1167–1175.
   PubMed Web of Science ®Google Scholar
• TRITTO FP, INSERTE J, GARCIA-DORADO D, RUIZ-MEANAM, SOLER-SOLER J: Sodium/hydrogen exchanger inhibition reduces myocardial reperfusion edema after normothermic cardioplegia. J. Thorac. Cardiovasc. Surg. (1998) 115:709–715.
   PubMed Web of Science ®Google Scholar
• SHIPOLINI AR, YOKOYAMA H, GALINANES M, EDMONDSON SJ, HEARSE DJ, AVKIRAN M: Neill+ exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation (1997) 96:3617–3625.
   PubMed Web of Science ®Google Scholar
• MATHUR S, KARMAZYN M: Interaction between anesthetics and the sodium-hydrogen exchange inhibitor HOE 642 (cariporide) in ischemic and reperfused rat hearts. Anesthesiology (1997) 87:1460–1469.
   PubMed Web of Science ®Google Scholar
• MATHUR S, FARHANGHKOEE P, KARMAZYN M: Cardio-protective effects of propofol and sevoflurane in ischemic and reperfused rat hearts. Role of KATP channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (Cariporide). Anesthesi-ology (1999) 91:1349–1360.
   Google Scholar
• ENG S, MADDAFORD TG, KARDAMI E, PIERCE GN: Protection against myocardial ischemic/reperfusion injury by inhibitors of two separate pathways of Na entry. J. Mol. Cell Cardiol. (1998) 30:829–835.
   PubMed Web of Science ®Google Scholar
• CHAKRABARTI S, HOQUE ANE, KARMAZYN M: A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (Cariporide). J. Mol Cell. Cardiol. (1997) 29:3169–3174.
   PubMed Web of Science ®Google Scholar
• HUMPHREYS RA, HAIST JV, CHAKRABARTI S, FENG QP, ARNOLD JMO, KARMAZYN M: Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion. Am. J. Physiol. (1999) 276:H749–H757.
   PubMed Web of Science ®Google Scholar
• GARCIA-DORADO D, GONZALEZ MA, BARRABES JA et al:Prevention of ischemic rigor contracture during coronary occlusion by inhibiting of Nat'l+ exchange. Cardiovasc. Res. (1997) 35:80–89.
   PubMed Web of Science ®Google Scholar
• KLEIN HH, BOHLE RM, PICH S, LINDERT-HEIMBERG S,WOLLENWEBER J, NEDENDAHL K: Time delay of cell death by Neal+ exchange inhibition in regionally ischemic, reperfused porcine hearts. J. Cardiovasc. Pharmacol. (1997) 30:235–240.
   PubMed Web of Science ®Google Scholar
• AYE NN, KOMORI S, HASHIMOTO K: Effects and interac-tion, of cariporide and preconditioning on cardiac arrhythmias and infarction in rat in vivo. Br. J. Pharmacol. (1999) 127:1048–1055.
   PubMed Web of Science ®Google Scholar
• MIURA T, OGAWA T, SUZUKI K, GOTO M, SHIMAMOTOK: Infarct size limitation by a new Na+-11+ exchange inhibitor, Hoe 642: Difference from preconditioning in the role of protein kinase C../ Am. Coll Cardiol (1997) 29:693–701.
   PubMed Web of Science ®Google Scholar
• LINZ W, ALBUS U, CRAUSE P et al.: Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642). Clin. Exp. Hypertens. (1998) 20:733–749.
   PubMed Web of Science ®Google Scholar
• KLEIN H, BOHLE RM, PICH S et al.: Time-dependent protection by Neill+ exchange inhibition in a region-ally ischemic, reperfused porcine heart preparation with low residual blood flow. J. Mol. Cell. Cardiol. (1998) 30:795–801.
   PubMed Web of Science ®Google Scholar
• AYE NN, XUE YX, HASHIMOTO K: Antiarrhythmic effects of cariporide, a novel Nat'l+ exchange inhibitor, on reperfusion ventricular arrhythmias in rat hearts. Eur. J. Pharmacol. (1997) 339:121–127.
   PubMed Web of Science ®Google Scholar
• XUE YX, AYE NN, HASHIMOTO K: Anti-arrhythmic effects of H0E642, a novel Na+-11+ exchange inhibitor, on ventricular arrhythmias in animal hearts. Eur. J. Pharmacol. (1996) 317:309–316.
   PubMed Web of Science ®Google Scholar
• SUGIYAMA A, AYE NN, SAWADA N, HASHIMOTO K: Cariporide, a highly selective Neill+ exchange inhibitor, supresses the reperfusion-induced lethal arrhythmias and 'overshoot' phenomenon of creatine phosphate in situ rat heart. J. Cardiovasc. Pharmacol. (1999) 33:116–121.
   PubMed Web of Science ®Google Scholar
• DHEIN S, KRUSEMANN K, ENGELMANNN F, GOTTWALD M: Effects of the type-1 Neal+ exchange inhibitor cariporide (Hoe 642) on cardiac tissue. Naunyn-Schmiedeberg's. Arch. Pharmacol. (1998) 357:662–670.
   Google Scholar
• HARTMANN M, DECKING UKM: Blocking Na+-11+ exchange by cariporide reduces Na+ -overload in ischemia and is cardioprotective. j Mol. Cell. Cardiol (1999) 31:1985–1995.
   PubMed Web of Science ®Google Scholar
• HOQUE AN, KARMAZYN M: Effect of sodium-hydrogenexchange inhibition on functional and metabolic impairment produced by oxidative stress in the isolated rat heart. Can. J. Physiol. Pharmacol. (1997) 75:326–334.
   PubMed Web of Science ®Google Scholar
• MYERS ML, FARHANGKHOEE P, KARMAZYN M: Hydrogen peroxide induced impairment of post-ischemic ventricular function is prevented by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Cardiovasc. Res. (1998) 40:290–296.
   PubMed Web of Science ®Google Scholar
• MARTIN J, SARAI K, YOSHOTAKE M et al.: Orthotopictransplantation of pig hearts harvested after 30 min of normothermic ischemia: controlled reperfusion with blood cardioplegia containing the Na+-11+ exchange inhibitor HOE 642. Eur. J. Cardiothorac. Surg. (1998) 14:607–614.
   PubMed Web of Science ®Google Scholar
• KIM YI, HERIJGERS P, LAYCOCK SK, VAN LOMMEL A, VERBEKEN E, FLAMENG WJ: Neill+ exchange inhibi-tion improves long-term myocardial preservation. Ann. Thorac. Surg. (1998) 66:436–442.
   PubMed Web of Science ®Google Scholar
• KIM YI, HERIJGERS P, VAN LOMMEL A, VERBEKEN E, FLAMENG WJ: Neal+ exchange inhibition improves post-transplant myocardial compliance in 4-hour stored donor hearts. Cardiovasc. Surg. (1998) 6:67–75.
   PubMedGoogle Scholar
• YOSHIDA H, KARMAZYN M: Neill+ exchange inhibi-tion attenuates hypertrophy and heart failure in 1-wk postinfarction rat myocardium. Am. J. Physiol. (2000) 278:H300–H304.
   PubMed Web of Science ®Google Scholar
• FERGUSON JJ: Highlights of the 48th scientific sessionsof the American College of Cardiology. Circulation (1999) 100:570–575.
   PubMedGoogle Scholar
• DREXLER H, JOACHIM H, BUERKE M et al.: A Neal+exchange inhibitor improves recovery of ventricular function in patients undergoing coronary angioplasty fore acute anterior myocardial infarction. Circulation (1998) 98:1-344 (Abstract).
   Google Scholar
• GUMINA RJ, MIZUMURA T, BEIER N, SCHELLING P,SCHULTZ JJ, GROSS GJ: A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary artery occlusion. J. Pharmacol. Exp. Ther. (1998) 286:175–183.
   PubMed Web of Science ®Google Scholar